Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 23.12%398.58M | ---- | -9.45%600.74M | ---- | -14.83%323.73M | ---- | -15.42%663.47M | ---- | -12.80%380.1M |
| Profit adjustment | ||||||||||
| Impairment and provisions: | ---- | 257.80%49.67M | ---- | 171.53%171.68M | ---- | -11.40%13.88M | ---- | 359.82%63.23M | ---- | -37.52%15.67M |
| -Other impairments and provisions | ---- | 227.53%46.87M | ---- | 27.75%45.17M | ---- | 10.16%14.31M | ---- | 368.51%35.36M | ---- | 1.42%12.99M |
| Asset sale loss (gain): | ---- | 116.45%53.01 | ---- | 99.86%-5.94K | ---- | 72.13%-322.2 | ---- | -164.20%-4.35M | ---- | -100.02%-1.16K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 116.45%53.01 | ---- | 99.86%-5.94K | ---- | 72.13%-322.2 | ---- | -164.20%-4.35M | ---- | -100.02%-1.16K |
| Depreciation and amortization: | ---- | 1.41%258.45M | ---- | 9.24%511.21M | ---- | 15.45%254.86M | ---- | 12.73%467.96M | ---- | 12.00%220.75M |
| -Amortization of intangible assets | ---- | 1.28%246.4M | ---- | 9.67%486.97M | ---- | 16.99%243.28M | ---- | 14.23%444.04M | ---- | 12.83%207.96M |
| -Other depreciation and amortization | ---- | 0.84%1.11M | ---- | 31.37%2.2M | ---- | 91.42%1.1M | ---- | 73.08%1.68M | ---- | 41.63%574.82K |
| Financial expense | ---- | -19.79%185.28M | ---- | -6.24%439.02M | ---- | 2.02%231M | ---- | 0.19%468.25M | ---- | 2.01%226.42M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -79.77%1.64M | ---- | 205.38%12.94M | ---- | 437.42%8.09M | ---- | -76.31%-12.28M | ---- | 164.02%1.51M |
| Accounts receivable (increase)decrease | ---- | -281.56%-221.77M | ---- | 61.92%-266.61M | ---- | 89.11%-58.12M | ---- | -24.73%-700.07M | ---- | 6.88%-533.67M |
| Accounts payable increase (decrease) | ---- | 82.01%-45.56M | ---- | -269.26%-23.25M | ---- | -702.11%-253.26M | ---- | -79.19%13.73M | ---- | 17.08%-31.57M |
| Special items of business | ---- | -74.25%5.97M | ---- | -140.89%-7.25M | ---- | 172.19%23.19M | ---- | -46.65%17.73M | ---- | -18.75%8.52M |
| Adjustment items of business operations | 25.46%1.32B | 20.39%626.27M | 21.49%272.11M | 50.60%1.45B | 60.04%1.05B | 86.31%520.18M | 117.38%223.97M | -18.40%959.94M | 51.12%659.04M | 5.62%279.2M |
| Net cash from operations | 25.46%1.32B | 16.36%632.24M | 21.49%272.11M | 47.13%1.44B | 60.04%1.05B | 88.86%543.37M | 117.38%223.97M | -19.17%977.68M | 51.12%659.04M | 4.69%287.72M |
| Cash flow from investment activities | ||||||||||
| Sale of fixed assets | -98.78%132.66K | -99.97%2.92K | ---- | -66.78%10.93M | -66.48%10.88M | 40,154.16%10.87M | ---- | -66.33%32.9M | -66.76%32.46M | -99.97%27.02K |
| Purchase of fixed assets | 28.11%-210.02M | 27.42%-157.34M | 19.36%-115.59M | 48.74%-370.14M | 51.92%-292.15M | 47.09%-216.79M | 39.10%-143.33M | 41.58%-722.13M | 37.50%-607.62M | 40.72%-409.74M |
| Other items in the investment business | 32.41%2.7M | ---- | -92.92%1.24K | 1,194.55%2.04M | 150.67%2.04M | ---- | --17.56K | 101.02%157.52K | -115.13%-4.02M | 82.35%-4.02M |
| Net cash from investment operations | 25.80%-207.19M | 23.59%-157.34M | 19.35%-115.58M | 48.17%-357.17M | 51.79%-279.23M | 50.23%-205.92M | 39.10%-143.31M | 37.96%-689.08M | 31.69%-579.18M | 27.82%-413.74M |
| Net cash before financing | 43.91%1.12B | 40.73%474.91M | 94.05%156.52M | 274.67%1.08B | 870.98%775.5M | 367.77%337.45M | 160.98%80.66M | 191.86%288.6M | 119.40%79.87M | 57.77%-126.02M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -50.91%1.61B | -48.54%1.21B | 46.40%653.85M | 96.28%3.94B | 99.24%3.28B | 80.98%2.35B | 263.73%446.63M | -6.50%2.01B | -4.83%1.64B | -11.32%1.3B |
| Refund | 49.44%-1.77B | 35.98%-1.47B | -137.29%-670.3M | -78.06%-4.45B | -77.60%-3.51B | -36.30%-2.29B | 41.68%-282.48M | 18.33%-2.5B | 21.57%-1.98B | 28.05%-1.68B |
| Dividends paid - financing | -4.69%-529.85M | 58.14%-169.94M | 20.09%-84.95M | -17.03%-731.47M | -6.33%-506.12M | -92.43%-405.96M | -0.21%-106.31M | 0.09%-625.03M | 3.59%-475.98M | 13.82%-210.96M |
| Other items of the financing business | -68.00%-3.47M | -282.38%-2.35M | -361.96%-1.28M | -14.13%-3.43M | 25.99%-2.07M | 74.96%-615.83K | 81.33%-277.47K | 53.50%-3.01M | 50.86%-2.79M | 36.63%-2.46M |
| Net cash from financing operations | 5.83%-700.19M | -22.66%-432.68M | -278.37%-102.68M | -11.20%-1.25B | 8.39%-743.52M | 41.09%-352.74M | 112.27%57.56M | -238.14%-1.12B | -176.21%-811.65M | -148.67%-598.83M |
| Effect of rate | -191.84%-11.29K | -314.59%-12.14K | -1,302.81%-2.74K | 105.83%17.24K | 98.65%-3.87K | -77.65%5.66K | 98.79%-195.22 | -272.94%-295.8K | -1,565.45%-285.68K | 152.91%25.33K |
| Net Cash | 1,200.17%415.83M | 376.13%42.22M | -61.05%53.84M | 80.20%-164.74M | 104.37%31.98M | 97.89%-15.29M | 122.98%138.22M | -191.42%-831.95M | -212.03%-731.78M | -177.77%-724.85M |
| Begining period cash | -15.95%867.81M | -15.95%867.81M | -15.95%867.81M | -44.63%1.03B | -44.63%1.03B | -44.63%1.03B | -44.63%1.03B | 95.31%1.86B | 95.31%1.86B | 95.31%1.86B |
| Cash at the end | 20.58%1.28B | -10.54%910.02M | -21.28%921.65M | -15.95%867.81M | -6.02%1.06B | -10.76%1.02B | -7.33%1.17B | -44.63%1.03B | -29.55%1.13B | -39.58%1.14B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.